Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Kronos Bio Q2 2024 EPS $(0.27), Sales $2.69M Beat $1.52M Estimate

Author: Benzinga Newsdesk | August 08, 2024 05:35pm

Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(0.27) per share. The company reported quarterly sales of $2.69 million which beat the analyst consensus estimate of $1.52 million by 76.26 percent. This is a 44.21 percent increase over sales of $1.86 million the same period last year.

Posted In: KRON


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist